To include your compound in the COVID-19 Resource Center, submit it here.

NuCana gains on first-line biliary cancer readout

NuCana plc (NASDAQ:NCNA) jumped $6.02 (42%) to $20.51 on Friday after reporting interim data from the Phase

Read the full 175 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE